Brent Pfeiffenberger
-
Century Therapeutics Expands Pipeline with Type 1 Diabetes Drug Candidate
Philadelphia-based Century Therapeutics is broadening its drug development pipeline with a new candidate aimed at treating Type 1 diabetes, an autoimmune disease that affects 2…
Founding Partners
Advertisement
Affiliate Partners
